A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats.

MLA

Ichikawa, Hiroshi, et al. “A Specific Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-Gamma) Ligand, Pioglitazone, Ameliorates Gastric Mucosal Damage Induced by Ischemia and Reperfusion in Rats.” Redox Report : Communications in Free Radical Research, vol. 7, no. 5, 2002, pp. 343–46. EBSCOhost, https://doi.org/10.1179/135100002125000956.

APA

Ichikawa, H., Naito, Y., Takagi, T., Tomatsuri, N., Yoshida, N., & Yoshikawa, T. (2002). A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats. Redox Report : Communications in Free Radical Research, 7(5), 343–346. https://doi.org/10.1179/135100002125000956

Chicago

Ichikawa, Hiroshi, Yuji Naito, Tomohisa Takagi, Naoya Tomatsuri, Norimasa Yoshida, and Toshikazu Yoshikawa. 2002. “A Specific Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-Gamma) Ligand, Pioglitazone, Ameliorates Gastric Mucosal Damage Induced by Ischemia and Reperfusion in Rats.” Redox Report : Communications in Free Radical Research 7 (5): 343–46. doi:10.1179/135100002125000956.